Facilitating EMA binding test performance using fluorescent beads combined with next‐generation sequencing

Abstract The eosin‐5′‐maleimide (EMA) binding test is widely used as diagnostic test for hereditary spherocytosis (HS), one of the most common haemolytic disorders in Caucasian populations. We recently described the advantages of replacing the use of healthy control blood samples with fluorescent be...

Full description

Bibliographic Details
Main Authors: Andreas Glenthøj, Christian Brieghel, Amina Nardo‐Marino, Richard vanWijk, Henrik Birgens, Jesper Petersen
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:eJHaem
Subjects:
Online Access:https://doi.org/10.1002/jha2.277